Table 5.
CR group | MD group | |||||||
---|---|---|---|---|---|---|---|---|
Eicosanoids | Before intervention | After intervention | Before intervention | After intervention | ||||
Mean | (SD) | Mean | (SD) | Mean | (SD) | Mean | (SD) | |
Reduction of >1.5 kg | No significant changes | |||||||
Reduction of > 2.5 kg | No significant changes | |||||||
Reduction of >3 kg | Before intervention | After intervention | Before intervention | After intervention | ||||
Mean | (SD) | Mean | (SD) | Mean | (SD) | Mean | (SD) | |
LTX5S6R15R | 0.087 | 0.091 | 0.07 | 0.083 | 0.16 | 0.129 | 0.12 | 0.148 |
16RS-HETE | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
13S-HODE | 0.012 | 0.017 | 0.007 | 0.01 | 0.015 | 0.012 | 0.015 | 0.017 |
9S-HODE | 0.045 | 0.054 | 0.023 | 0.031 | 0.048 | 0.037 | 0.042 | 0.049 |
15S-HETE | 0.068 | 0.064 | 0.04 | 0.049 | 0.102* | 0.067 | 0.051* | 0.054 |
12S-HETE | 0.265 | 0.267 | 0.157 | 0.172 | 0.378 | 0.301 | 0.191 | 0.23 |
5-oxo-ETE | 0.015 | 0.018 | 0.01 | 0.011 | 0.016 | 0.014 | 0.015 | 0.016 |
p<0.05